UN SDG #3 Good Health and Well-being UN SDG #3

solution provider

0 shares

Griffin Deep Genomics Platform

When a disease is developing in the body, the affected cells die and shed into the bloodstream. Life-threatening diseases like cancer leave a unique combination of mutations in the DNA of these dead cells. By investigating every single copy of cell-free DNA in a blood sample, we can gain a uniquely deep and comprehensive insight into the body’s current health status.

solution provider

0 shares

Griffin Deep Genomics Platform

When a disease is developing in the body, the affected cells die and shed into the bloodstream. Life-threatening diseases like cancer leave a unique combination of mutations in the DNA of these dead cells. By investigating every single copy of cell-free DNA in a blood sample, we can gain a uniquely deep and comprehensive insight into the body’s current health status.

Benefits

AI & Machine Learning

Our clinical data pipeline continues to grow and provides us with valuable insights into early cancer detection patterns.

Quantgene’s technology uses a redesigned sequencing process.

The GRIFFIN CORE is a proprietary software infrastructure

Main Features

Combining Deep Genomic sequencing and AI to detect disease down to a single molecule.

Primary Audience

Clinicians, technologists, data scientists, and business innovators

Benefits

AI & Machine Learning

Our clinical data pipeline continues to grow and provides us with valuable insights into early cancer detection patterns.

Quantgene’s technology uses a redesigned sequencing process.

The GRIFFIN CORE is a proprietary software infrastructure

Main Features

Combining Deep Genomic sequencing and AI to detect disease down to a single molecule.

Primary Audience

Clinicians, technologists, data scientists, and business innovators

Learn More

Jo Bhakdi

Founder & Chief Executive Officer

Quantgene

We’re not a cancer company, we are a health protection and peace of mind company.